Jacek Romatowski

Statistics

Publications

Citations

756

H-Index

Active since

2011

Affiliations

University of California San Diego(Current)

Pfizer (United States)

Cornell University

Brigham and Women's Hospital

University Clinical Hospital In Bialystok

Jacek Romatowski is an author at University of California San Diego specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and ulcerative colitis pharmacotherapy.

Publications per year

2011–2024

Publications

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

Bruce E. Sands, Peter M. Irving, Timothy Hoops et al. · The Lancet · 2022 · 297 citations · Full text

Medicine, Clinical Sciences, Immunology +17

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

Laurent Peyrin‐Biroulet, Jessica R. Allegretti, David T. Rubin et al. · Gastroenterology · 2023 · 92 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study

Silvio Danese, Maria Kłopocka, Ellen Scherl et al. · Clinical Gastroenterology and Hepatology · 2021 · 91 citations · Full text

Life Sciences, Immunology, Autoimmunity +12

Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study

William J. Sandborn, Silvio Danese, Jarosław Leszczyszyn et al. · Clinical Gastroenterology and Hepatology · 2023 · 89 citations

Pharmacy, Pharmacology, Pharmacotherapy +9

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 83 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

1–5 of 10